News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roxane Laboratories, Inc. Announces the Launch of Galantamine Hydrobromide Oral Solution


8/25/2009 10:43:41 AM

COLUMBUS, Ohio, Aug. 24 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the availability of Galantamine Hyrdrobromide Oral Solution, 4mg/mL as of August 14, 2009. The product, indicated for mild to moderate dementia related to Alzheimer's disease, is available for immediate shipment to wholesalers and pharmacies nationwide. Currently this product is available as a generic from Roxane Laboratories.

Read at PR Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES